SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001798749-23-000015
Filing Date
2023-03-29
Accepted
2023-03-29 17:04:43
Documents
78
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20221231x10k.htm   iXBRL 10-K 2391035
2 EX-21.1 tmb-20221231xex21d1.htm EX-21.1 3732
3 EX-23.1 tmb-20221231xex23d1.htm EX-23.1 2298
4 EX-31.1 tmb-20221231xex31d1.htm EX-31.1 11072
5 EX-31.2 tmb-20221231xex31d2.htm EX-31.2 11017
6 EX-32.1 tmb-20221231xex32d1.htm EX-32.1 5947
7 EX-32.2 tmb-20221231xex32d2.htm EX-32.2 6058
8 GRAPHIC tmb-20221231x10k001.jpg GRAPHIC 42853
9 GRAPHIC tmb-20221231x10k002.jpg GRAPHIC 38845
10 GRAPHIC tmb-20221231x10k003.jpg GRAPHIC 38464
11 GRAPHIC tmb-20221231x10k004.jpg GRAPHIC 51323
12 GRAPHIC tmb-20221231x10k005.jpg GRAPHIC 96290
13 GRAPHIC tmb-20221231x10k006.jpg GRAPHIC 62041
14 GRAPHIC tmb-20221231x10k007.jpg GRAPHIC 24508
15 GRAPHIC tmb-20221231x10k008.jpg GRAPHIC 52409
16 GRAPHIC tmb-20221231x10k009.jpg GRAPHIC 45828
17 GRAPHIC tmb-20221231x10k010.jpg GRAPHIC 75124
18 GRAPHIC tmb-20221231x10k011.jpg GRAPHIC 34016
  Complete submission text file 0001798749-23-000015.txt   9978721

Data Files

Seq Description Document Type Size
19 EX-101.SCH tmb-20221231.xsd EX-101.SCH 40912
20 EX-101.CAL tmb-20221231_cal.xml EX-101.CAL 58926
21 EX-101.DEF tmb-20221231_def.xml EX-101.DEF 173274
22 EX-101.LAB tmb-20221231_lab.xml EX-101.LAB 417383
23 EX-101.PRE tmb-20221231_pre.xml EX-101.PRE 337002
72 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20221231x10k_htm.xml XML 1580145
Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40544 | Film No.: 23776053
SIC: 2834 Pharmaceutical Preparations